rVSV-ZEBOV is a recombinant vesicular stomatitis virus-based vaccine that has been genetically engineered to express a glycoprotein from the Zaire strain of the Ebola virus (EBOV). This vaccine is designed to induce an immune response against Ebola, offering protection against this highly fatal disease.
